NICE will assess digital therapies for tic disorders and Tourette syndrome to determine whether they can be recommended for use in the NHS, based on the available evidence and cost-saving potential. Tics are fast, repetitive muscle movements that result in difficult to control body movements or sounds. Some tics involve body movements (motor) or sounds (phonic). Examples of tics may include: blinking, grimacing, head jerking, head banging, finger clicking, coughing, grunting, sneezing, repeating a sound or phrase. Tics can lead to significant pain and discomfort and can cause distress. Young people may find that tic disorders can interfere with school and in their social lives. The NICE health technology assessment will evaluate innovative digitally enabled therapies for tics and Tourette syndrome. It will review the evidence that is available and assess the potential clinical and cost-effectiveness of the technologies, as well as identifying evidence gaps to help direct data collection.
 
 
Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Further information Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process MTEP

Provisional Schedule

Draft guidance 19 November 2024 - 17 December 2024
Committee meeting: 2 20 February 2025
Resolution 26 March 2025
Expected publication 24 April 2025

Project Team

Project lead Liz Islam

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
26 September 2024 In progress
12 September 2024 Declaration of interests
15 August 2024 Committee meeting
24 January 2024 Scope published
08 November 2023 Launch